Studies have shown that active fund managers routinely underperform the S&P500 index*​

Assembly Biosciences, Inc. (NASDAQ: ASMB)

ASMB Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-37.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
87%

ASMB Stock Analysis

ASMB PE Ratio: 352

ASMB PEG Ratio: Not Available

ASMB Forward EPS Growth (12 month): 0.00%

ASMB PS Ratio:

ASMB PSG Ratio:

ASMB Forward Revenue Growth (12 month): -15.10%

ASMB Articles

No data was found